Search Results - "Son, Ilhong"
-
1
Nuclear α-Synuclein-Derived Cytotoxic Effect via Altered Ribosomal RNA Processing in Primary Mouse Embryonic Fibroblasts
Published in International journal of molecular sciences (21-01-2023)“…α-Synuclein (αSyn) is an important player in Parkinson's disease (PD) pathogenesis. The aggregation of αSyn is mainly formed in the cytoplasm, whereas some…”
Get full text
Journal Article -
2
An early endosome regulator, Rab5b, is an LRRK2 kinase substrate
Published in Journal of biochemistry (Tokyo) (01-06-2015)“…Leucine-rich repeat kinase 2 (LRRK2) has been identified as a causative gene for Parkinson's disease (PD). LRRK2 contains a kinase and a GTPase domain, both of…”
Get full text
Journal Article -
3
Expression of transduced nucleolin promotes the clearance of accumulated α-synuclein in rodent cells and animal model
Published in Neurobiology of disease (01-07-2021)“…Alpha-synuclein (αSyn) is a major component of Lewy bodies, which are a known pathogenic marker of Parkinson's disease (PD). The dysfunction of protein…”
Get full text
Journal Article -
4
Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors
Published in Current issues in molecular biology (01-05-2024)“…Astrocytes in the brain contribute to various essential functions, including maintenance of the neuronal framework, survival, communication, metabolic…”
Get full text
Journal Article -
5
LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss
Published in Cells (Basel, Switzerland) (02-03-2022)“…Evidence suggests that crosstalk occurs between microglial leucine-rich repeat kinase 2 (LRRK2)-a regulator of neuroinflammation-and neuron-released…”
Get full text
Journal Article -
6
Therapeutic Effect of Padina arborescens Extract on a Cell System Model for Parkinson's Disease
Published in NeuroSci (01-09-2024)“…Leucine-rich repeat kinase 2 (LRRK2) and α-synuclein are involved in the pathogenesis of Parkinson's disease. The activity of LRRK2 in microglial cells is…”
Get full text
Journal Article -
7
G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
Published in BioMed research international (01-01-2016)“…The LRRK2 mutation is a major causal mutation in familial Parkinson’s disease. Although LRRK2 contains functional GTPase and kinase domains and their…”
Get full text
Journal Article -
8
G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses
Published in Animal cells and systems (04-03-2019)“…Leucine rich-repeat kinase 2 (LRRK2) is involved in the pathogenesis of Parkinson's disease (PD). LRRK2 has kinase and GTPase activities, and mediates several…”
Get full text
Journal Article -
9
Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson’s Disease
Published in Parkinson's disease (01-01-2018)“…Parkinson’s disease (PD) is the second most common neurodegenerative disease. Oxidative stress is the most critical risk factor for neurodegenerative diseases,…”
Get full text
Journal Article -
10
Effect of leucine-rich repeat kinase 2 (LRRK2) on protein synthesis
Published in Animal cells and systems (02-01-2018)“…Mutations in the leucine-rich repeat kinase 2 (LRRK2) cause Parkinson's disease (PD) in an autosomal dominant manner. Pathogenic mutations of LRRK2 such as…”
Get full text
Journal Article -
11
Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson's disease
Published in Animal cells and systems (17-02-2021)“…Research on Parkinson's disease (PD) has been focused on the development of PD diagnostic tools as much as the development of PD therapeutics. Several genetic…”
Get full text
Journal Article -
12
KCHO-1, a novel herbal anti-inflammatory compound, attenuates oxidative stress in an animal model of amyotrophic lateral sclerosis
Published in Journal of veterinary science (Suwŏn-si, Korea) (01-12-2017)“…Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by selective death of motor neurons in the central nervous system. The main…”
Get full text
Journal Article -
13
Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial
Published in Current controlled trials in cardiovascular medicine (13-04-2018)“…Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes paralysis of limb, swallowing, and breathing muscles. Riluzole, the Food…”
Get full text
Journal Article -
14
Effect of leucine-rich repeat kinase 2 (LRRK2) on protein synthesis
Published in Animal cells and systems (2018)“…Mutations in the leucine-rich repeat kinase 2 (LRRK2) cause Parkinson's disease (PD) in an autosomal dominant manner. Pathogenic mutations of LRRK2 such as…”
Get full text
Journal Article -
15
Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity
Published in Animal cells and systems (03-09-2018)“…Leucine-rich repeat kinase 2 (LRRK2) is involved in Parkinson's disease (PD) pathology. A previous study showed that rotenone treatment induced apoptosis,…”
Get full text
Journal Article -
16
26-Week Repeated Dose Oral Toxicity Study of KCHO-1 in Sprague-Dawley Rats
Published in Journal of pharmacopuncture (01-09-2019)“…KCHO-1(Mecasin), also called Gamijakyakgamchobuja-tang originally, is a combination of some traditional herbal medicines in East Asia. This medicine has been…”
Get full text
Journal Article -
17
Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression
Published in Molecular brain (06-10-2017)Get full text
Journal Article -
18
Characterization of Parkinson's disease-related pathogenic TMEM230 mutants
Published in Animal cells and systems (04-03-2018)“…Parkinson's disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5-10% of them are hereditary and several…”
Get full text
Journal Article -
19
Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression
Published in Molecular brain (18-09-2015)“…Background Leucine-rich repeat kinase 2 (LRRK2) is a gene in which a mutation causes Parkinson's disease (PD), and p53 is a prototype tumor suppressor. In…”
Get full text
Journal Article -
20
Dexamethasone induces the expression of LRRK2 and α-synuclein, two genes that when mutated cause Parkinson's disease in an autosomal dominant manner
Published in BMB reports (01-09-2013)“…LRRK2 (leucine-rich repeat kinase 2) has been identified as a gene corresponding to PARK8, an autosomal-dominant gene for familial Parkinson's disease (PD)…”
Get full text
Journal Article